Cellular and molecular stimulation of adipose-derived stem cells under hypoxia

• Published in: Cell biology international Vol. 38; no. 5; pp. 553 - 562
• Main Authors: Kang, Sangjin, Kim, Soo-Min, Sung, Jong-Hyuk
• Format: Journal Article
• Language: English
• Published: England Blackwell Publishing Ltd 01.05.2014; Wiley Subscription Services, Inc
• Subjects: Adipocytes - metabolism; Adipose Tissue - cytology; Adipose Tissue - metabolism; adipose-derived stem cells; Animals; Cell Differentiation - physiology; Cell Hypoxia - physiology; Cells, Cultured; Humans; Hypoxia; hypoxia inducible factor-1α; miR-210; Phosphorylation; reactive oxygen species; Reactive Oxygen Species - metabolism; Rodents; Stem cells; Stem Cells - metabolism; adipose-derived stem cells; hypoxia; hypoxia inducible factor-1α; miR-210; reactive oxygen species
• ISSN: 1065-6995; 1095-8355
• DOI: 10.1002/cbin.10246

Cultivation under hypoxia has beneficial effects on adipose‐derived stem cells (ASCs). Despite a history of extensive research on the responses of ASCs to hypoxia, investigations have focused on functional alterations of ASCs. Therefore, we provide novel insight in this review into the cellular and molecular changes that occur in ASCs under hypoxic conditions. Hypoxia increases the proliferation and migration of ASCs by the generation of reactive oxygen species (ROS) and downstream phosphorylation of platelet‐derived growth factor receptor‐beta, ERK1/2, and Akt. Chronically, activation of these signaling pathways upregulates miR‐210 via phosphorylation of NF‐κB and Elk1. Protein tyrosine phosphatase, non‐receptor type 2 (PTPN2) is a direct miR‐210 target, and downregulation of PTPN2 mediates the proliferation and migration of ASCs during hypoxia. In addition, the paracrine effect of ASCs is enhanced under hypoxic conditions, irrespective of whether ROS are generated. Hypoxic preconditioning stabilizes hypoxia inducible factor‐1α under hypoxic conditions and increases secretion of vascular endothelial growth factor, thereby improving the regenerative potential of ASCs. Therefore, understanding the cellular and molecular changes that occur during hypoxia is highly relevant for the development of novel ASC therapies.